Compounds > satavaptan
Page last updated: 2024-09-04

satavaptan and Inappropriate ADH Syndrome

satavaptan has been researched along with Inappropriate ADH Syndrome in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (50.00)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K1
Laczi, F1
Villabona, C1
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N1
Kettritz, R; Luft, FC1
Coffernils, M; Couturier, B; Decaux, G; Gankam-Kengne, F; Soupart, A1
Bichet, DG1
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G1
Gross, P; Herbrig, K; Palm, C; Pistrosch, F1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P1
Ahrabi, AK; Caron, N; Devuyst, O; Horie, S; Nielsen, S; Raufaste, D; Serradeil-Le Gal, C; Terryn, S; Valenti, G; Verbavatz, JM1
Alföldi, S; Annane, D; Decaux, G; Gross, P; Heshmati, HM; Legros, JJ; Soupart, A1

Reviews

8 review(s) available for satavaptan and Inappropriate ADH Syndrome

ArticleYear
Management of hyponatremia.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, May-13, Volume: 186, Issue:8

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome

2014
[Etiology, diagnostics and therapy of hyponatremias].
    Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins

2008
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance

2011
[Disorders of fluid and electrolyte balance].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:48

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Deamino Arginine Vasopressin; Humans; Hyperkalemia; Hypernatremia; Hyponatremia; Inappropriate ADH Syndrome; Membrane Potentials; Morpholines; Osmolar Concentration; Potassium; Randomized Controlled Trials as Topic; Sodium; Spiro Compounds; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance

2011
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins

2003
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    The American journal of medicine, 2006, Volume: 119, Issue:7 Suppl 1

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins

2006
Therapeutic potential of vasopressin receptor antagonists.
    Drugs, 2007, Volume: 67, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2007

Trials

2 trial(s) available for satavaptan and Inappropriate ADH Syndrome

ArticleYear
Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
    Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Urea

2012
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.
    Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Body Water; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Placebos; Sodium; Spiro Compounds

2006

Other Studies

2 other study(ies) available for satavaptan and Inappropriate ADH Syndrome

ArticleYear
What is the role of vaptans in routine clinical nephrology?
    Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:5

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Male; Morpholines; Spiro Compounds; Tolvaptan; Urea

2012
PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Calcium; Cell Polarity; Disease Models, Animal; Diuresis; Female; Haplotypes; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Morpholines; Osmolar Concentration; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Spiro Compounds; TRPP Cation Channels; Water-Electrolyte Balance

2007